Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors, The PNeoVCA Study

Conditions:   Anatomic Stage III Breast Cancer AJCC v8;   Anatomic Stage IIIA Breast Cancer AJCC v8;   Anatomic Stage IIIB Breast Cancer AJCC v8;   Anatomic Stage IIIC Breast Cancer AJCC v8;   Anatomic Stage IV Breast Cancer AJCC v8;   Clinical Stage III Cutaneous Melano ma AJCC v8;   Clinical Stage III Gastric Cancer AJCC v8;   Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8;   Clinical Stage III Merkel Cell Carcinoma AJCC v8;   Clinical Stage IV Cutaneous Melanoma AJCC v8;   Clinical Stage IV Gastric Cancer AJCC  v8;   Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8;   Clinical Stage IV Merkel Cell Carcinoma AJCC v8;   Clinical Stage IVA Gastric Cancer AJCC v8;   Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8;   Clinical Stage IVB Gastric Cancer  AJCC v8;   Clinical Stage IVB Gastroesophageal Junction Adenocarcinoma AJCC v8;   Locally Advanced Cervical Carcinoma;   Locally Advanced Endometrial Carcinoma;   Locally Advanced Gastric Adenocarcinoma;   Locally Advanced Gastroesophageal Junction Adenocarcinoma;   Locally Advanced Head and Neck Squamous Cell Carcinoma;   Locally Advanced Hepatocellular Carcinoma;   Locally Advanced Lung Non-Small Cell Carcinoma;   Locally Advanced Malignant Solid Neoplasm;   Locally Advanced Melanoma;   Locally Advanced Merkel Cell Carcinoma;   Locally A...
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials